Drug Shortage Report for CEFTIN

Last updated on 2024-02-14 History
Report ID 173951
Drug Identification Number 02212307
Brand name CEFTIN
Common or Proper name CEFTIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) CEFUROXIME
Strength(s) 125MG
Dosage form(s) GRANULES FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 100ML
ATC code J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-11-01
Estimated end date 2023-10-06
Actual end date 2023-10-02
Shortage status Resolved
Updated date 2024-02-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2024-02-14 English Compare
v18 2023-10-03 English Compare
v17 2023-10-02 French Compare
v16 2023-10-02 English Compare
v15 2023-07-10 French Compare
v14 2023-07-10 English Compare
v13 2023-05-30 French Compare
v12 2023-05-30 English Compare
v11 2023-04-04 French Compare
v10 2023-04-04 English Compare
v9 2023-01-20 French Compare
v8 2023-01-20 English Compare
v7 2023-01-19 English Compare
v6 2022-12-12 French Compare
v5 2022-12-12 English Compare
v4 2022-12-08 English Compare
v3 2022-11-08 French Compare
v2 2022-11-08 English Compare
v1 2022-11-08 English Compare

Showing 1 to 19 of 19